AstraZeneca
1,872.00 SEK
-0.61 %
Less than 1K followers
AZN
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.61 %
+13.49 %
+9.89 %
+8.40 %
+24.06 %
+15.41 %
+37.95 %
+127.43 %
+10,143.22 %
AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.
Read moreMarket cap
2.9T SEK
Turnover
420.99M SEK
Revenue
540.24B
EBIT %
23.4 %
P/E
30.84
Dividend yield-%
1.57 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
9/4
2026
General meeting '26
29/4
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
AstraZeneca: Filing of Annual Report on Form 20-F with the US Securities and Exchange Commission
AstraZeneca: Annual Financial Report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools